Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
he received dose one of Shingrix in 2019 and has not yet had the 2nd dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2019). The patient did not receive the 2nd dose of Shingrix. The patient had incomplete course of vaccination (Verbatim: he received dose one of Shingrix in 2019 and has not yet had the 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 21-JUL-2025 The reporter was an older male who states that he received dose one of Shingrix in 2019 and has not yet had the 2nd dose. He stated that his wife also received her first dose in 2021 and has not yet had the 2nd dose. The reporter did not have patient identifiers for the wife. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. This case had been linked with US2025093099, reported by the same reporter.; Sender's Comments: US-GSK-US2025093099:Same reporter,different patient